Creutzfeldt-Jakob disease (CJD), a progressive dementia of humans, is caused by an infectious agent that is closely related to the scrapie agent of sheep. Although the molecular nature of these "unconventional" agents is still a matter of speculation and controversy, even less is known concerning the mechanism(s) of their effects on the central nervous system. To gain insight into the cellular effects of these agents, we have examined a series of cell lines derived directly from CJD-infected hamster brain or produced from nontransformed rodent lines by exposure to CJD infectious fractions in vitro. These cell lines appear transformed by a variety of criteria and secrete growth factors into the culture medium. All CJD lines produce a factor that is like a-transforming growth factor (a-TGF). Conditioned medium from these CJD lines also stimulates the synthesis of glial fibrillary acidic protein in normal astrocytic cells in vitro. This effect is mimicked by purified a-TGF and platelet-derived growth factors. Further study of CJD-induced growth factor production may elucidate fundamental properties of these unconventional agents.
The molecular nature of the agents (7) causing the unconventional viral diseases (Creutzfeldt-Jakob disease [CJD] , scrapie, kuru) is still a matter of intense speculation and controversy (16, 18, 25, 26) . Little attention has been given to the observation that cells from scrapie-infected brains readily produce permanent or immortalized lines in vitro (3, 4, 8, 12) . Furthermore, in more than 20 independent attempts, cells from almost all CJD-infected mouse and hamster brains yielded permanent cell lines, while cells from control brains generally gave rise to senescent cultures (12) . We have also recently shown that in vitro exposure of BALB/c 3T3 cells and other normal early-passage primary rodent cell lines to CJD infectious preparations reproducibly induces transformation, whereas treatment of the same lines with normal brain preparations does not (24) . This and other biological properties are reminiscent of retroviruses (17) . However, up to the present time no retroviruses or other conventional viruses known to elicit either central nervous system disease or transformation have been demonstrated in normal or CJD-infected brain tissue, despite a careful search by many investigators.
In each of two cultures assayed, inoculations of homogenized long-term (multiply passaged) CJD cell lines produced the characteristic incubation features, clinical symptoms, and histologic brain lesions of CJD (12) . These data indicated that the agent was obviously replicating in these lines. The titer of infectivity was significantly lower than in CJDinfected brain tissue and thus the cell lines are not an ideal source for agent purification. We considered that detailed characterization of the transformed phenotype of these cell lines could provide insight into fundamental biologic properties of the agent which relate to its central nervous system effects. This initial study demonstrates that all CJD-transformed cell lines, whether derived from brain or treated in vitro with infectious material, appear to produce a factor that is like a-transforming growth factor (a-TGF). This result suggests that the CJD agent has induced transformation by a similar mechanism in each cell line. The potential in vivo significance of this phenomenon is illustrated by the ability of conditioned media from CJD-transformed cell lines (as well as purified a-TGF) to increase glial fibrillary acidic protein (GFAP) production in vitro. This effect mimics the increased astroglial GFAP production seen during the course of the disease in vivo (13, 19) .
MATERIALS AND METHODS
Cell lines. Immortalized cell lines from CJD-infected mouse (TC 740 and TC 746) and hamster brains (TC 724 and TC 728) were established from explant cultures as previously described (12) . The passages utilized in these studies are capable of forming tumors in nude mice and can therefore be considered transformed (11, 14, 17; unpublished data (24) .
Anchorage-independent growth in soft agar was determined essentially as described by McPherson and Montagnier (20) . BALB/c 3T3 cells (1 x 103 to 5 x 103) were suspended in 1.2% methylcellulose F4M (Dow Chemical Co.) with DMEM and 10% fetal calf serum containing 300 ,ul of conditioned medium per ml and plated on a base layer of 0.9% agar (Bacto; Difco Laboratories). At 1 week later, cells were refed with fresh medium and 150 RI of conditioned medium. Colonies of >20 cells were scored 2 weeks after initial plating, as previously depicted (24) . Tests with SeaPlaque agarose (FMC Corp.) generated comparable results.
EGF radioreceptor assay. Epidermal growth factor (EGF)-like factors were quantitated by a commercial radioreceptor assay on the basis of A431 cell membranes (Biomedical Technologies), following the protocol of the manufacturer. The ability of portions of concentrated conditioned medium to compete with 1251I-labeled EGF binding was compared with purified EGF standards.
GFAP immunocytochemistry. Early-passage normal mouse brain cells were seeded onto eight chamber slides (Miles Scientific) at 1 x 104 to 2 x 104 cells per chamber. After attachment, concentrated conditioned medium or purified growth factors were added for an additional 3 to 4 days. After being rinsed in serum-free DMEM, cells were fixed for 5 min with buffered 4% paraformaldehyde and they were permeabilized for 1 min with cold methanol. GFAP immunoreactivity was determined with a non-species-specific polyclonal anti-GFAP kit (Miles Scientific), using the peroxidase-antiperoxidase method. This antibody selectively delineates GFAP fibrils in reactive astrocytes in brain as previously depicted (19) . Notably, conditioned medium from control TC 509, derived from a methylcholanthrene-induced glioblastoma which produces type C virus, had no comparable stimulatory effect.
RESULTS
In order to quantitate growth factor production, conditioned medium was concentrated 20-to 70-fold by ultrafiltration and the effects of serial dilutions of this concentrate on 3T3 cell DNA synthesis were assayed. The resultant Concentrated conditioned medium, expressed as milliliter equivalents of original conditioned medium, i.e., 0.1 ml of a 1Ox concentrate, is equal to a 1-ml equivalent of conditioned medium. Cultures treated with brain homogenates are designated with an H and those treated with synaptosome-enriched fractions are designated SM.
dose-response curves (Fig. 1 [bottom] ) show that the amount of growth factor produced by the series of CJD cell lines varies over nearly a two-log range. In general, 3T3 cell lines exposed to CJD in vitro produce the least amount of growth factor. However, this low production of growth factor appears to relate to the underlying cellular phenotype rather than to the process of in vitro exposure, because a normal hamster brain cell line similarly exposed to CJD in vitro (TC 744A/CJ) produced large amounts of growth factor. Its control counterpart exposed to uninfectious brain (TC 744A/ N) produced no significant comparable growth factor. Conditioned medium from CJD cultures also stimulated anchorage-independent growth of indicator cells. Table 1 shows the effect of culture supematants of CJD lines on 3T3 cell colony formation in soft agar compared with that of the supernatants of various control lines. Again, all CJD lines, whether derived from brain tissue or by in vitro treatment, stimulated colony formation, whereas control lines did not. Table 2 summarizes the biochemical properties of the growth factor(s) produced by CJD lines. The mitogenic factor is trypsin labile but heat and acid stable. These properties are consistent with a low-molecular-weight peptide factor. The sensitivity to treatment with dithiothreitol suggests that the factor consists of peptide chains joined by disulfide bonds (like PDGF or P-TGF) or has functionally important intrachain disulfide bonds (like EGF and a-TGF) (9, 21).
The above-mentioned biologic activities and biochemical properties of the CJD-induced growth factor are all fulfilled by a-TGF. Because o-TGF binds with high affinity to EGF e 100 ,ug of trypsin inhibitor per ml in the presence of 50 ,ug of trypsin (Sigma) per ml for 2 h at 37°C. f 50 pg/ml at 37C for 2 h. 8 Dithiothreitol (DIT) treatment was at 0.065 M for 2 h at 22°C, followed by dialysis against saline.
receptors, concentrated conditioned media from control and CJD cell lines were therefore evaluated in an EGF radioreceptor assay (Fig. 2) . The conditioned medium from the CJD cell lines contained varying amounts of EGF-like activity equivalent to 60 to 600 pg per ml of EGF (10-10 to 10-11 M). This concentration of ot-TGF may be sufficient to account for the observed stimulations of DNA synthesis and anchorage-independent growth in the indicator BALB/c 3T3 cells (1, 9) . However, a potentiation of ot-TGF activity by 3-TGF or other growth factors has not been ruled out.
Because a-TGF production appeared to be a fundamental feature of cell lines derived from CJD-infected brains, it was of interest to determine whether a-TGF could account for any of the observed in vivo effects of CJD infection. The most consistent morphologic feature of CJD is hypertrophy and possibly hyperplasia of astrocytes (gliosis). Biochemically, this hypertrophy is the consequence of a markedly increased production of the astroglial-specific intermediate filament GFAP. To date, most studies of the effects of peptide growth factor effects on astrocytes have focused on the stimulation of cellular proliferation (27, 32) , although one preliminary study suggested that fibroblast growth factor can regulate GFAP expression (5) . Therefore, the effects of conditioned medium from the CJD cell lines and purified oa-TGF on GFAP production in low-passage mouse brain cell cultures were examined. After a 3-day incubation, these cells showed a modest increase in saturation density, a prominent increase in branching astrocytic processes, and a markedly increased amount of immunocytochemically detectable GFAP (Fig. 3) . Conditioned media from all CJD lines induced this effect while that from control cultures (including the glioblastoma line TC 509) did not. EGF and platelet-derived growth factor produced similar effects, while P-TGF alone had significantly less effect. The potency of conditioned medium in inducing these effects compared with that of the purified growth factors appeared somewhat greater than expected from its a-TGF-like factor content measured by the radioreceptor assay. Therefore, production of additional synergistic factors by the CJD lines cannot be ruled out.
DISCUSSION
The marked gliosis seen in brains infected with CJD is more than can be accounted for as a secondary response to tissue destruction (13) . In fact, the stimulation of GFAP gene expression (assessed as GFAP mRNA accumulation) temporally precedes the neuronal damage (19) , especially when selected brain regions are examined. The near-global activation of astrocytes is a fundamental part of the pathophysiology of this class of diseases. It could be the consequence of a direct interaction between the infectious agent and astrocytes, or it could be caused by an agent-induced factor which influences astrocytic gene expression throughout the brain.
The production of a-TGF activity by CJD-derived cell lines and the ability of conditioned medium (or purified growth factor) to stimulate GFAP expression in cultured astrocytes suggest that the second hypothesis deserves further consideration. Growth factor production is frequently a component of the transformed phenotype. However, many tumor lines, including the malignant glioma line used here as a control (TC 509), do not produce a-TGF activity. The relatively high initial growth rate of cells in primary cultures of CJD-infected brains suggests that the resultant established lines may have produced an a-TGF-like factor from their inception and prior to the acquisition of a complete transformed phenotype. These lines may be derived from cells induced in vivo to produce a-TGF by the CJD agent. The mechanism(s) of the stimulation of growth factor production by the unconventional CJD agent is presently unclear. Even in the limited sphere of viral transformation, there are clearly multiple distinct potential mechanisms involved. Both DNA and RNA viruses can directly encode growth factors (2, 30) . Additionally, oncogenic viruses can activate a variety of oncogenes by transduction or insertional mutagenesis, with consequent stimulation of growth factor production (21) . Both the underlying host cell phenotype and the specific oncogene(s) activated may determine which specific growth factor is produced. Notably however, all CJD lines, regardless of lineage, produce an a-TGF-like factor. Some glial cell lines have been shown to produce factors that are like platelet-derived growth factor (23) and contain v-sis-related mRNA (6) . The exact lineage of the transformed CJD brain lines is uncertain, because of their poorly differentiated state.
On a broader level, the as yet undefined relationship between the transformed phenotype of CJD cells and the neurophathology of infectious dementias may prove to be of critical importance. Although the gliosis present in CJDinfected brains approaches levels reminiscent of low-grade astrocytomas (13) , hamsters infected with CJD or scrapie do not develop obvious brain tumors. However, it is now apparent that tumorigenesis typically requires the activation of more than a single oncogene (10) . In addition, oncogenic potential need not be expressed within the central nervous system as obvious tumor formation. The cells infected by the transforming JC papovavirus have a cytologically malignant phenotype, yet the gross pathologic lesion in adult brain is typically demyelination (33) . Similarly, transgenic mice carrying an activated simian virus 40 T-antigen gene develop a demyelination syndrome (28) , although tumors may be produced in visceral organs (22) . In this context, the investigation of oncogenic expression in infectious dementias is a novel and potentially fruitful avenue of research. 
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